[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342933-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342933-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","establishment-and-molecular-characterization-of-hcb541-a-novel-and-aggressive-human-cutaneous-squamous-cell-carcinoma-cell-line","Establishment and molecular characterization of HCB‑541, a novel and aggressive human cutaneous squamous cell carcinoma cell line","","Cutaneous squamous cell carcinoma (cSCC) is commonly managed and rarely metastasizes, yet limited availability of commercial cSCC cell lines restricts mechanistic studies. This work establishes a new metastatic cSCC cell line, HCB-541, from a Brazilian patient biopsy via immortalization. Comprehensive profiling evaluates cytokeratin expression, karyotypic changes, mutational landscape, differential mRNA/protein expression, xenograft tumorigenicity, and drug sensitivity. HCB-541 shows rapid growth, MSI-H, pathogenic TP53/HRAS/TERT alterations, strong xenograft tumorigenicity, and high sensitivity to platinum drugs and EGFR inhibitors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/establishment-and-molecular-characterization-of-hcb541-a-novel-and-aggressive-human-cutaneous-squamous-cell-carcinoma-cell-line/342933/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/establishment-and-molecular-characterization-of-hcb541-a-novel-and-aggressive-human-cutaneous-squamous-cell-carcinoma-cell-line/342933.png","ImageObject",300,407,{"name":42,"@type":43},"Maeve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of establishing the HCB-541 cell line?","Question",{"text":63,"@type":64},"To establish and characterize a new metastatic cSCC cell line derived from a Brazilian patient, enabling biological modeling for metastatic skin cancer research and therapy studies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which molecular and genomic features were reported for HCB-541?",{"text":68,"@type":64},"HCB-541 displayed hypodiploid/hypotetraploid populations, pathogenic mutations in TP53 (p.(Arg248Leu)), HRAS (Gln61His), and TERT promoter (C228T), and high-level microsatellite instability (MSI-H) in both tumor and cell line.",{"name":70,"@type":61,"acceptedAnswer":71},"How did HCB-541 perform in functional and therapeutic testing?",{"text":72,"@type":64},"The cell line showed a doubling time of 20–30 hours and high tumorigenic capacity in xenograft mice, with high phosphorylated EGFR/AXL/Tie/FGFR/ROR2 levels and high sensitivity to cisplatin, carboplatin, and EGFR inhibitors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342933,1790798516,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","Human Cell (2024) 37:1170–1183  \n[https://doi.org/10.1007/s13577-024-01054-1](https://doi.org/10.1007/s13577-024-01054-1)  \nEstablishment and molecular characterization of HCB‑541, a novel and aggressive human cutaneous squamous cell carcinoma cell line  \nAna Carolina Laus1 · Izabela Natalia Faria Gomes1 · Aline Larissa Virginio da Silva1 · Luciane Sussuchi da Silva1 · Mirella Baroni Milan1 · Silvia AparecidaTeixeira1 · Ana Carolina Baptista Moreno Martin1 · Letícia do Nascimento Braga Pereira1 ·  \nCarlos Eduardo Barbosa de Carvalho2 · Camila Souza Crovador2 · Flávia Escremin de Paula1 · Flávia Caroline Nascimento1 · Helder Teixeira de Freitas1 · Vinicius de LimaVazquez1,2 ·  \nRui Manuel Reis1,3,4,5 · Renato José da Silva‑Oliveira1,5  \nReceived: 16 December 2023 / Accepted: 4 March 2024 / Published online: 3 April 2024 © The Author(s) 2024  \nAbstract  \nCutaneous squamous cell carcinoma (cSCC) is a common type of skin cancer that can result in significant morbidity, although it is usually well-managed and rarely metastasizes. However, the lack of commercially available cSCC cell lines hinders our understanding of this disease. This study aims to establish and characterize a new metastatic cSCC cell line derived from a Brazilian patient. A tumor biopsy was taken from a metastatic cSCC patient, immortalized, and named HCB-541 after several passages. The cytokeratin expression profile, karyotypic alterations, mutational analysis, mRNA and protein differential expression, tumorigenic capacity in xenograft models, and drug sensitivity were analyzed. The HCB-541 cell line showed a doubling time between 20 and 30 h and high tumorigenic capacity in the xenograft mouse model. The HCB-541 cell line showed hypodiploid and hypotetraploidy populations. We found pathogenic mutations in TP53 p.(Arg248Leu), HRAS (Gln61His) and TERT promoter (C228T) and high-level microsatellite instability (MSI-H) in both tumor and cell line. We observed 37 cancer-related genes differentially expressed when compared with HACAT control cells. The HCB-541 cells exhibited high phosphorylated levels of EGFR, AXL, Tie, FGFR, and ROR2, and high sensitivity to cisplatin, carboplatin, and EGFR inhibitors. Our study successfully established HCB-541, a new cSCC cell line that could be useful as a valuable biological model for understanding the biology and therapy of metastatic skin cancer.  \nKeywords Cutaneous squamous cell carcinoma · Molecular profile · Cell line establishment · In vivo model  \n* Renato José da Silva-Oliveira [renatokjso@gmail.com](renatokjso@gmail.com)  \n1 Molecular Oncology Research Center, Barretos Cancer Hospital, Antenor Duarte Villela, 1331, Barretos, São Paulo Zip Code: 14784 400, Brazil  \n2 Department of Surgery of Melanoma and Sarcoma, Barretos Cancer Hospital, São Paulo, Brazil  \n3 Life and Health Sciences Research Institute (ICVS) Medical School, University of Minho, Braga, Portugal  \n4 ICVS/3B’s-PT Government Associate Laboratory, Braga/Guimarães, Portugal  \n5 Barretos School of Health Sciences, Dr. Paulo Prata-FACISB, Barretos, São Paulo, Brazil  \nIntroduction  \nCutaneous squamous cell carcinoma (cSCC) is a prevalent type of nonmelanoma skin cancer, accounting for 20% of all skin cancer cases [1]. Its incidence is increasing in most white populations globally [1] . Depending on the origin of the tumor, cSCC can be classified as cutaneous or invasive. Cutaneous cSCCs arise from keratinocyte proliferation, while invasive cSCCs arise from intraepidermal dysplasia [2]. The primary risk factors for cSCC development include exposure to ultraviolet radiation, chemical carcinogens, immunodeficiency, chronic inflammation, and precursor pre-malignant conditions, including Bowen’s disease, actinic keratosis, and keratoacanthomas [3–5] .  \nThe European guideline categorizes cSCCs as primary or advanced, depending on the extent of tumor spread, and  \nprimary cSCCs are typically non-metastatic and easily treatable, whereas advanced cSCCs are classified","cbCaikWlQsKDEE5g","https://ap.wps.com/l/cbCaikWlQsKDEE5g","pdf",3163227,14,"English","# Abstract\n# Introduction","[{\"question\":\"What is the purpose of establishing the HCB-541 cell line?\",\"answer\":\"To establish and characterize a new metastatic cSCC cell line derived from a Brazilian patient, enabling biological modeling for metastatic skin cancer research and therapy studies.\"},{\"question\":\"Which molecular and genomic features were reported for HCB-541?\",\"answer\":\"HCB-541 displayed hypodiploid/hypotetraploid populations, pathogenic mutations in TP53 (p.(Arg248Leu)), HRAS (Gln61His), and TERT promoter (C228T), and high-level microsatellite instability (MSI-H) in both tumor and cell line.\"},{\"question\":\"How did HCB-541 perform in functional and therapeutic testing?\",\"answer\":\"The cell line showed a doubling time of 20–30 hours and high tumorigenic capacity in xenograft mice, with high phosphorylated EGFR/AXL/Tie/FGFR/ROR2 levels and high sensitivity to cisplatin, carboplatin, and EGFR inhibitors.\"}]","Establishment and molecular characterization of HCB‑541, a novel and aggressive human cutaneous squamous cell carcinoma cell line | PDF",1790048912,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/005f10ef3a31cd346ec949de10cbf161.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be18f15acbb1ec5a16acb4d1f80c4b23.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/796d603bbd7d2d8f3ddf0bbe1891cd42.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d64226ed5e8f6bf9fc965ecace9bc44.webp",980,1301]